Sai Life Sciences Limited has received a tax demand order totaling ₹32.86 crore from the Joint Commissioner of Commercial Taxes (Appeals). The demand comprises ₹16.28 crore for Integrated Goods and Services Tax (IGST), ₹13.32 crore for interest, and ₹3.26 crore for a penalty.
This order stems from allegations of excess availment of Input Tax Credit (ITC) for the financial year 2021-22. The company received the order on April 29, 2026, and has announced its intention to file an appeal against it.
The tax demand represents a significant potential financial liability for Sai Life Sciences if the appeal is unsuccessful. This situation highlights ongoing compliance considerations and the financial risks associated with tax disputes. The company's legal and finance teams are expected to manage the appeal process, with stakeholders closely monitoring its progress and outcome.
The next steps will involve Sai Life Sciences formally filing its appeal with the relevant Tribunal. Observers will watch for any interim orders from the Tribunal and the eventual resolution of the case, which will determine the final financial implications.
